<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25184928</article-id>
      <article-id pub-id-type="pmc">4155967</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20142897</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Livedoid vasculopathy as a marker of systemic disease: report of two
cases<xref ref-type="fn" rid="fn01">*</xref>
</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Lima</surname>
            <given-names>Raquel Sucupira Andrade</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Maquin&#xE9;</surname>
            <given-names>Gustavo &#xC1;vila</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Talhari</surname>
            <given-names>Carolina</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="aff" rid="aff02">2</xref>
          <xref ref-type="aff" rid="aff03">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Encarna&#xE7;&#xE3;o</surname>
            <given-names>Isabel Cristina Lima</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schettini</surname>
            <given-names>Ant&#xF4;nio Pedro Mendes</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Santos</surname>
            <given-names>M&#xF4;nica</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="aff" rid="aff02">2</xref>
          <xref ref-type="aff" rid="aff03">3</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label> Funda&#xE7;&#xE3;o Alfredo da Matta (FUAM) - Manaus (AM), Brazil.</aff>
      <aff id="aff02"><label>2</label> Universidade do Estado do Amazonas (UEA) - Manaus (AM), Brazil.</aff>
      <aff id="aff03"><label>3</label> Universidade Nilton Lins - Manaus (AM), Brazil.</aff>
      <author-notes>
        <corresp id="c01"><bold><italic>MAILING ADDRESS:</italic></bold> M&#xF4;nica Santos, Avenida Codajas, 25, Cachoeirinha,
69065-130 - Manaus - AM, Brazil. E-mail: <email>m.n.souza.santos@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Sep-Oct</season>
        <year>2014</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Sep-Oct</season>
        <year>2014</year>
      </pub-date>
      <volume>89</volume>
      <issue>5</issue>
      <fpage>822</fpage>
      <lpage>824</lpage>
      <history>
        <date date-type="received">
          <day>26</day>
          <month>6</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>9</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2014 by Anais Brasileiros de Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited. </license-p>
        </license>
      </permissions>
      <abstract>
        <p>The livedoid vasculopathy is an obstructive vascular process of etiology not yet
fully known, being possibly associated with several prothrombotic events. It is
clinically characterized by the presence of painful and recurring purpuric lesions,
which usually suffer ulceration and evolve with formation of white atrophic scars
usually located in the lower limbs. Two cases are here reported of painful ulcerated
lesions on the lower limbs, in which the identification of VL enabled the diagnosis
of systemic diseases.</p>
      </abstract>
      <kwd-group>
        <kwd>Atrophy</kwd>
        <kwd>Leg ulcer</kwd>
        <kwd>Skin diseases, vascular</kwd>
        <kwd>Thrombosis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Livedoid vasculopathy (LV) is an obstructive vascular process of etiology not yet fully
known, possibly associated with several prothrombotic events, initially described by
Millian, in 1929, who designated it as white atrophy.<sup><xref rid="r01" ref-type="bibr">1</xref></sup> In 1967, Bard and Winkelman reported livedoid
vasculopathy in patients with segmental hyalinizing alteration of small dermal
vessels.<sup><xref rid="r02" ref-type="bibr">2</xref></sup> For a long time, the
term "livedoid vasculitis" was used as a synonym of the disease, but it is no longer
accepted, for findings compatible with vasculitis are not present in the histological
exam.<sup><xref rid="r03" ref-type="bibr">3</xref></sup> Two cases with painful
ulcerated lesions on the lower limbs are reported, in which the identification of VL
enabled the diagnosis of systemic diseases.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p><bold>Case 1 -</bold> Female patient, 27 years old, for seven years had outbreaks of
painful ulcers on the lower limbs (<xref ref-type="fig" rid="f01">Figure 1</xref>).
<bold>Case 2</bold> - Female patient, 29 years old, for four years had intensely
painful purpuric lesions, which evolved with localized ulcerations on legs and feet
(<xref ref-type="fig" rid="f02">Figure 2</xref>). At the physical examination, both
presented ulcers with irregular borders, clean background, in different progression
stages, some of them with a white-pearly coloration, in addition to scars on lower
limbs. The histopathological exams of both cases showed segmental hyaline thickening of
vessel walls, fibrinoid deposits and hyaline thrombi in the vascular lumen, red blood
cell extravasation and discrete inflammatory infiltrate, confirming the LV diagnosis
(<xref ref-type="fig" rid="f03">Figure 3</xref>). An extensive investigation of
autoimmune diseases and prothrombotic states was performed. In case 1, the lipoprotein-a
(Lp(a)) was positive (123mg/dL - reference value &lt;30). In case 2, anticardiolipin
antibody was positive in two samples with interval of 12 weeks. This patient also
reported previous history of abortions with less than 10 weeks, characterizing
Antiphospholipid syndrome (APS). Both cases were prescribed aspirin and pentoxifylline
with complete cicatrization of lesions in case 1. Case 2 was followed-up in conjunction
with rheumatology and prescribed pulse therapy with cyclophosphamide and oral prednisone
in an immunosuppressive dose. Both patients are in clinical remission, with periodical
ambulatory follow-up, after 12 (case 1) and 18 months (case 2) since initial diagnosis
(<xref ref-type="fig" rid="f04">Figure 4</xref>).</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p><bold>Case 1:</bold> Ulcerated lesions and atrophic scars located on the dorsum of
feet</p>
        </caption>
        <graphic xlink:href="abd-89-05-0822-g01"/>
      </fig>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p><bold>Case 2:</bold> Erythematouspurpuric lesions and ulceration located in medial
and malleolar region of left foot</p>
        </caption>
        <graphic xlink:href="abd-89-05-0822-g02"/>
      </fig>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Fibrinoid deposits with hyaline thickening of vessel walls; extravasation of red
blood cells and hyaline thrombi into vascular lumen (HE 200 and 400x)</p>
        </caption>
        <graphic xlink:href="abd-89-05-0822-g03"/>
      </fig>
      <fig id="f04" orientation="portrait" position="float">
        <label>FIGURE 4</label>
        <caption>
          <p><bold>A</bold> (case 1) and <bold>B</bold> (case 2): cicatrization of ulcers, with
some atrophic lesions and residual A hyperchromia</p>
        </caption>
        <graphic xlink:href="abd-89-05-0822-g04"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>LV is clinically characterized by the presence of painful and recurring purpuric
lesions, which usually suffer ulceration, evolving with formation of whitish atrophic
scars, located on the lower limbs. The disease usually progresses in outbreaks, with
periods of seasonal exacerbation.<sup><xref rid="r04" ref-type="bibr">4</xref></sup> Its
pathogenesis is not yet fully understood, however the vaso-occlusive theory is currently
the most widely accepted. Some factors underlie this theory: the histopathological
analysis with the presence of hyaline thrombi in most cases, good response to the
treatment of prothrombotic states and the several reports associated with
thrombophilia.<sup><xref rid="r05" ref-type="bibr">5</xref>,<xref rid="r06" ref-type="bibr">6</xref></sup> More rarely, the disease has been associated with the
lipoprotein-a, which is considered an independent risk factor for coronary artery
disease.<sup><xref rid="r07" ref-type="bibr">7</xref>,<xref rid="r08" ref-type="bibr">8</xref></sup> The reporting of these cases reinforce this association
since patient 1 presents LV associated to high levels of Lp(a) and patient 2 was
diagnosed with APS from the identification of LV. The differential diagnosis of LV is
done mainly with cutaneous vasculitides and anticoagulant drugs can be employed for its
treatment (warfarin, heparin, or fibrinolytics) as well as antiplatelet agents such as
acetylsalicylic acid. Vasodilating drugs, such as pentoxifylline, can still be used. In
cases associated with autoimmune diseases, immunosuppressants are also used.<sup><xref rid="r09" ref-type="bibr">9</xref>,<xref rid="r10" ref-type="bibr">10</xref></sup></p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>Conflict of Interests: None.</p>
      </fn>
      <fn fn-type="other">
        <p>How to cite this article: Lima RSA, Maquin&#xE9; GA, Talhari C, Encarna&#xE7;&#xE3;o ICL, Schettini
APM, Santos M. Livedoid vasculopathy as a marker of systemic disease: report of two
cases. An Bras Dermatol. 2014;89(5):822-4.</p>
      </fn>
      <fn fn-type="financial-disclosure">
        <p>Financial Support: None</p>
      </fn>
      <fn id="fn01" fn-type="other">
        <label>*</label>
        <p>Work performed at Funda&#xE7;&#xE3;o Alfredo da Matta (FUAM) - Manaus (AM), Brazil.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chang</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rajiv</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Livedoid Vasculopathy</article-title>
          <source>Cutis</source>
          <year>2012</year>
          <volume>90</volume>
          <fpage>179</fpage>
          <lpage>181</lpage>
          <page-range>179, 181-2</page-range>
          <pub-id pub-id-type="pmid">23259203</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gonzalez-Santiago</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
          <article-title>Update of management of connective tissue diseases: livedoid
vasculopathy</article-title>
          <source>Dermatol Ther</source>
          <year>2012</year>
          <volume>25</volume>
          <fpage>183</fpage>
          <lpage>194</lpage>
          <pub-id pub-id-type="pmid">22741937</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pulido-P&#xE9;rez</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Avil&#xE9;s-Izquierdo</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Su&#xE1;rez-Fern&#xE1;ndez</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous Vasculitis</article-title>
          <source>Actas Dermosifiliogr</source>
          <year>2012</year>
          <volume>103</volume>
          <fpage>179</fpage>
          <lpage>191</lpage>
          <pub-id pub-id-type="pmid">21839977</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Criado</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Rivitti</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Sotto</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Valente</surname>
              <given-names>NY</given-names>
            </name>
            <name>
              <surname>Aoki</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>JF</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Livedoid vasculopathy: an intringuing cutaneous
disease</article-title>
          <source>An Bras Dermatol</source>
          <year>2011</year>
          <volume>86</volume>
          <fpage>961</fpage>
          <lpage>977</lpage>
          <pub-id pub-id-type="pmid">22147037</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Feng</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Jin</surname>
              <given-names>PY</given-names>
            </name>
            <name>
              <surname>Shao</surname>
              <given-names>CG</given-names>
            </name>
          </person-group>
          <article-title>The significance of anticardiolipin antibody and immunologic
abnormality in livedoid vasculitis</article-title>
          <source>Int J Dermatol</source>
          <year>2011</year>
          <volume>50</volume>
          <fpage>21</fpage>
          <lpage>23</lpage>
          <pub-id pub-id-type="pmid">21182497</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jorge</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Fantini</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Rivitti</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Benabou</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Vasconcelos</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Criado</surname>
              <given-names>PR</given-names>
            </name>
          </person-group>
          <article-title>Frequency analysis of thrombophilia in patients with atrophie
blanche</article-title>
          <source>An Bras Dermatol</source>
          <year>2007</year>
          <volume>82</volume>
          <fpage>25</fpage>
          <lpage>33</lpage>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Criado</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Rivitti</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Sotto</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>de Carvalho</surname>
              <given-names>JF</given-names>
            </name>
          </person-group>
          <article-title>Livedoid vasculopathy as a coagulation disorder</article-title>
          <source>Autoimmun Rev</source>
          <year>2011</year>
          <volume>10</volume>
          <fpage>353</fpage>
          <lpage>360</lpage>
          <pub-id pub-id-type="pmid">21184847</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vasconcelos</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Criado</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Belda Jr</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Livedoid Vasculopathy secondary to high levels of
lipoprotein(a)</article-title>
          <source>Br J Dermatol</source>
          <year>2011</year>
          <volume>164</volume>
          <fpage>1111</fpage>
          <lpage>1113</lpage>
          <pub-id pub-id-type="pmid">21219292</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haunson</surname>
              <given-names>GT</given-names>
            </name>
            <name>
              <surname>Judy</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Prall</surname>
              <given-names>NC</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Livedoid Vasculopathy: Review of pathogenesis, clinical presentation,
diagnostic workup, and treatment</article-title>
          <source>Cutis</source>
          <year>2012</year>
          <volume>90</volume>
          <fpage>302</fpage>
          <lpage>306</lpage>
          <pub-id pub-id-type="pmid">23409480</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davis</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Wysokinski</surname>
              <given-names>WE</given-names>
            </name>
          </person-group>
          <article-title>Ulcerations caused by livedoid vasculopathy associated with a
prothrombotic state: response to warfarin</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2008</year>
          <volume>58</volume>
          <fpage>512</fpage>
          <lpage>515</lpage>
          <pub-id pub-id-type="pmid">18280355</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
